» Articles » PMID: 37377854

Occupational Lung Disease: when Should I Think of It and Why is It Important?

Overview
Journal Breathe (Sheff)
Specialty Pulmonary Medicine
Date 2023 Jun 28
PMID 37377854
Authors
Affiliations
Soon will be listed here.
Abstract

Exposure to toxic inhalants in the workplace has the potential to cause (in susceptible individuals) almost any major type of lung disease, such as asthma, COPD and interstitial lung diseases. Patients with occupational lung disease will often present to or will be managed by respiratory specialists without training in occupational respiratory medicine, and patients (or their clinicians) may not identify a link between their disease and their current or a past job. Without an awareness of the range of different occupational lung diseases that exist, their similarity to their non-occupational counterparts, and without directed questioning, these conditions may go unidentified. Patients with occupational lung diseases are often in lower paid work and are disproportionally affected by health inequality. Both clinical and socioeconomic outcomes generally improve if cases are identified early. This allows appropriate advice to be given about the risks of ongoing exposure, clinical management, occupational mobility and, in some cases, eligibility for legal compensation. As respiratory professionals, it is important that these cases are not missed, and if needed, are discussed with a physician with specialised expertise. Here we describe some of the most common occupational lung diseases and outline the diagnostic and treatment approach.

Citing Articles

Responses of an Coculture Alveolar Model for the Prediction of Respiratory Sensitizers (ALIsens) Following Exposure to Skin Sensitizers and Non-Sensitizers.

Burla S, Chary A, Serchi T, Cambier S, Sullivan K, Baker E Toxics. 2025; 13(1).

PMID: 39853027 PMC: 11769448. DOI: 10.3390/toxics13010029.


Formaldehyde and asthma: a plausibility?.

Wolkoff P Arch Toxicol. 2025; 99(3):865-885.

PMID: 39828805 DOI: 10.1007/s00204-024-03946-5.


Chemical respiratory sensitization-Current status of mechanistic understanding, knowledge gaps and possible identification methods of sensitizers.

Hargitai R, Parrakova L, Szatmari T, Monfort-Lanzas P, Galbiati V, Audouze K Front Toxicol. 2024; 6:1331803.

PMID: 39135743 PMC: 11317441. DOI: 10.3389/ftox.2024.1331803.


Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life Course.

Melen E, Zar H, Siroux V, Shaw D, Saglani S, Koppelman G Am J Respir Crit Care Med. 2024; 210(6):737-754.

PMID: 38981012 PMC: 11418887. DOI: 10.1164/rccm.202312-2249SO.


Climate change, the environment and respiratory disease.

Kent B Breathe (Sheff). 2023; 19(2):230102.

PMID: 37378882 PMC: 10292777. DOI: 10.1183/20734735.0102-2023.

References
1.
Jonsson E, Jarvholm B, Andersson M . Silica dust and sarcoidosis in Swedish construction workers. Occup Med (Lond). 2019; 69(7):482-486. PMC: 6913734. DOI: 10.1093/occmed/kqz118. View

2.
Torres-Duque C, Maldonado D, Perez-Padilla R, Ezzati M, Viegi G . Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc. 2008; 5(5):577-90. DOI: 10.1513/pats.200707-100RP. View

3.
Izbicki G, Chavko R, Banauch G, Weiden M, Berger K, Aldrich T . World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest. 2007; 131(5):1414-23. DOI: 10.1378/chest.06-2114. View

4.
Cullinan P, Vandenplas O, Bernstein D . Assessment and Management of Occupational Asthma. J Allergy Clin Immunol Pract. 2020; 8(10):3264-3275. DOI: 10.1016/j.jaip.2020.06.031. View

5.
Lioy P, Weisel C, Millette J, Eisenreich S, Vallero D, Offenberg J . Characterization of the dust/smoke aerosol that settled east of the World Trade Center (WTC) in lower Manhattan after the collapse of the WTC 11 September 2001. Environ Health Perspect. 2002; 110(7):703-14. PMC: 1240917. DOI: 10.1289/ehp.02110703. View